Researchers are utilizing generative AI to expedite drug development, significantly enhancing efficiency. This method involves AI algorithms creating molecular structures which streamline preclinical testing. The breakthrough could affect pharmaceutical companies globally and facilitate faster market-ready drugs, impacting healthcare systems profoundly.

Read More:

• 🔗 news.osu.edu